Gorgani, N. N., K. H. S. Kim, W. L. Free, M. Afkham, J. D. Henson, P. Shamanna, S. . Ajdari, C. R. . Kahn, T. R. . Hirst, A. H. . Barnett, and S. K. . Paul. “OZ101, an Oligofructose Prebiotic, May Prolong Sulphonylurea Efficcy in Patients With Type 2 Diabetes: A Pilot Study: OZ101 and Sulphonylurea-Mediated Glycaemic Control”. Journal of Current Medical Research and Opinion, vol. 5, no. 06, June 2022, pp. 1235-51, doi:10.52845/CMRO/2022/5-6-2.